Expression of substance P, neurokinin 1 receptor, Ki-67 and pyruvate kinase M2 in hormone receptor negative breast cancer and evaluation of impact on overall survival

[1] Turner BM(2021)Biomarker and multigene assay testing in ER positive, HER-2 negative breast carcinomas: an international guidelines-based approach Hum Pathol Rep 26 300574-35

[2] Katerji H(2005)Estrogen receptor-negative breast carcinomas: a review of morphology and immunophenotypical analysis Mod Pathol 18 26-11

[3] Zhang H(2008)A robust classifier of high predictive value to identify good prognosis patients in ER-negative breast cancer Breast Cancer Res 10 1-13

[4] Hicks DG(2009)Chronic inflammation, the tumor microenvironment and carcinogenesis Cell Cycle 8 2005-45

[5] Putti TC(2001)Inflammation and cancer: back to Virchow? The lancet 357 539-73

[6] Abd El-Rehim DM(2021)The role of chronic inflammation in the development of breast cancer Cancers 13 3918-71

[7] Rakha EA(2012)The relationship between components of tumour inflammatory cell infiltrate and clinicopathological factors and survival in patients with primary operable invasive ductal breast cancer Br J Cancer 107 864-9

[8] Paish CE(2012)Minireview: inflammation: an instigator of more aggressive estrogen receptor (ER) positive breast cancers Mol Endocrinol 26 360-70

[9] Lee AH(2009)A role for the substance P/NK-1 receptor complex in cell proliferation in oral squamous cell carcinoma Anticancer Res 29 2323-12

[10] Pinder SE(2005)Antitumoral action of the neurokinin-1-receptor antagonist L-733,060 and mitogenic action of substance P on human retinoblastoma cell lines Investig Ophthalmol Vis Sci 46 2567-69

[1] Turner BM(2021)Biomarker and multigene assay testing in ER positive, HER-2 negative breast carcinomas: an international guidelines-based approach Hum Pathol Rep 26 300574-35

[2] Katerji H(2005)Estrogen receptor-negative breast carcinomas: a review of morphology and immunophenotypical analysis Mod Pathol 18 26-11

[3] Zhang H(2008)A robust classifier of high predictive value to identify good prognosis patients in ER-negative breast cancer Breast Cancer Res 10 1-13

[4] Hicks DG(2009)Chronic inflammation, the tumor microenvironment and carcinogenesis Cell Cycle 8 2005-45

[5] Putti TC(2001)Inflammation and cancer: back to Virchow? The lancet 357 539-73

[6] Abd El-Rehim DM(2021)The role of chronic inflammation in the development of breast cancer Cancers 13 3918-71

[7] Rakha EA(2012)The relationship between components of tumour inflammatory cell infiltrate and clinicopathological factors and survival in patients with primary operable invasive ductal breast cancer Br J Cancer 107 864-9

[8] Paish CE(2012)Minireview: inflammation: an instigator of more aggressive estrogen receptor (ER) positive breast cancers Mol Endocrinol 26 360-70

[9] Lee AH(2009)A role for the substance P/NK-1 receptor complex in cell proliferation in oral squamous cell carcinoma Anticancer Res 29 2323-12

[10] Pinder SE(2005)Antitumoral action of the neurokinin-1-receptor antagonist L-733,060 and mitogenic action of substance P on human retinoblastoma cell lines Investig Ophthalmol Vis Sci 46 2567-69